A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 69
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CER
Long Form : cost-effectiveness ratio
No. Year Title Co-occurring Abbreviation
2019 Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. LYS, NBCSP, NCSP, PSA
2018 Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil. ICER, PC, PHS, SAH
2018 Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial). CR, GRA, HEC, ICER, JPY, PALO
2018 Process and Results of Implementing Disease Management Program in Patients with First-time Ischemic Stroke. DMP, IS, NIHSS
2017 Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. CAM, H. pylori, ICER, ITT, JPY, PPI, RPZ, VPZ
2017 Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus. DPP-4 Inhibitors, T2DM
2017 Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong. CHC, DAAs, HCV, PR, QALY, SVR
2017 Economic evaluation of infection control activities. ICT
2017 Otoacoustic Emissions in Rural Nicaragua: Cost Analysis and Implications for Newborn Hearing Screening. GDP, OAEs, RHC
10  2017 Strategies to Improve Management of Acute Watery Diarrhea during a Military Deployment: A Cost Effectiveness Analysis. DDL-averted, TD
11  2017 [Cost-effectiveness of community-based treatment of chronic hepatitis B in China]. CHB, ICER
12  2016 Cost effectiveness of different techniques in hallux valgus surgery. HV
13  2016 Cost-effectiveness analysis of ultrasound-guided Seldinger peripherally inserted central catheters (PICC). EI, PICC, US-Seldinger
14  2016 Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment. BMD, CBA, ICER
15  2016 Novel emergency department registration kiosk for HIV screening is cost-effective. DTS, ED
16  2016 Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis. CM, ICER, LYSs, QALYs, SNB, WE
17  2015 Cost effectiveness of response-guided therapy with peginterferon in the treatment of chronic hepatitis B. HBeAg, QALY
18  2015 Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. AS, BE, EAC, IAS
19  2015 Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria. ---
20  2015 Hepatitis C, disease and its management: a cost-effectiveness analysis of the new generation oral protease inhibitors. QALY, SMV/SOF, SOF/RBV
21  2015 The cost-effectiveness of interbody fusions versus posterolateral fusions in 137 patients with lumbar spondylolisthesis. PLF, PLIF, QALY
22  2015 Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. i.v, ICU, PN
23  2015 Who prefers the 'cost-effectiveness ratio' prioritization approach in health-care decisions? Results of an empirical analysis. ---
24  2015 [A study on the health economic evaluations of prevention of mother-to-child HIV transmission in Dehong prefecture, Yunnan province, China from 2004 to 2013]. PMTCT, QALY
25  2014 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension. IOP, OHT, POAG
26  2014 Cost-effectiveness of larviciding for urban malaria control in Tanzania. DALY, IVM, UI
27  2014 Costs of therapy with biologics in the treatment of moderate to severe plaque psoriasis in the context of the Italian health-care system. EMA, ICER, SSN
28  2014 [Effects, safety and cost-benefit analysis of Down syndrome screening in first trimester]. CBR, NIFTY, NPV, NT, PAPP-A
29  2013 Antibiotic sensitivity pattern and cost-effectiveness analysis of antibiotic therapy in an Indian tertiary care teaching hospital. CEA
30  2013 Comparison of the cost-effectiveness of stress myocardial perfusion MRI and SPECT in patients with suspected coronary artery disease. CAD, CEA, JPY, pMRI, SPECT
31  2013 Evaluating the translation process of an Internet-based self-help intervention for prevention of depression: a cost-effectiveness analysis. CBT, QALY
32  2013 [Health economics analysis of specific immunotherapy in allergic rhinitis accompanied with asthma]. ARAS, HDM, ICER, SIT, SIT
33  2013 [The cost-effectiveness analysis of gefitinib or erlotinib in the treatment of advanced EGFR mutant non-small cell lung cancer patients]. EGFR, ICEA, NSCLC, PFS
34  2012 Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. AMD, PSA, QALY, WTP
35  2011 Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. HPV, LYS, VIA
36  2011 Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness? HPV
37  2010 Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventions. WHO
38  2010 Routine HIV screening in France: clinical impact and cost-effectiveness. LE, QALM, QALY
39  2010 Statins: cost analysis in Indian scenario from eight major clinical trials. AFCAPS, ASCOT-LLA, CARE, CHD, HPS, LIPID, NNTB, WOSCOPS
40  2010 [Cost-effectiveness analysis of chemotherapy with GEM or S-1 for patients with non-resectable pancreatic cancer]. GEM, ICER, LMG
41  2008 Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting. ANOVA, CEE, INR
42  2007 Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis. CAPD, ESRD, HD
43  2007 Estimating the costs and health benefits of water and sanitation improvements at global level. DALY
44  2007 The cost-effectiveness of a school-based overweight program. CATCH, NB, NHANES, NHIS, QALYs
45  2007 [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer]. 5-FU, CRT, ICER, LYG
46  2006 Comparative cost-effectiveness of B-type natriuretic peptide and echocardiography for predicting outcome in patients with congestive heart failure. BNP, CHF
47  2005 Cost-effectiveness analysis of Malaysian neonatal intensive care units. MOH
48  2005 Cost-effectiveness of a low-carbohydrate diet and a standard diet in severe obesity. QALYs
49  2005 Policymaking based on CERs: changes in costs are not the same as changes in benefits. BPD, NBPD
50  2005 Surveillance for isocyanate asthma: a model based cost effectiveness analysis. QALY, SFD
51  2004 Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection. NFV, QALY, VL
52  2002 Abdominal aortic aneurysms: cost-effectiveness of elective endovascular and open surgical repair. AAAs, QALYs
53  2002 Cost-effectiveness analysis of gestational diabetes mellitus screening in France. OGTT
54  2002 The cost-effectiveness of a "quick-screen" program for abdominal aortic aneurysms. AAA
55  2002 Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. ---
56  2001 Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program. QALYs
57  2001 The effect of outliers on confidence interval procedures for cost-effectiveness ratios. ---
58  2001 [Cost-effectiveness analysis of hepatitis B vaccination in People's Liberation Army]. DALY
59  2000 Power and sample assessments for tests of hypotheses on cost-effectiveness ratios. ---
60  2000 [Cost-effectiveness analysis on two different measles immunization strategies]. ---
61  1999 Cost effectiveness evaluation of the Ministry of Health Malaysia dialysis programme. CAPD, HD, IPD, MOH
62  1999 Determining the cost-effectiveness of mass screening for cervical cancer using common analytic models. ---
63  1999 Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis? CEA
64  1999 Is thrombolysis of lower extremity acute arterial occlusion cost-effective? TOPAS
65  1999 Pharmaco-economic aspects of in-vitro fertilization in Italy. IVF, rFSH, uFSH
66  1998 [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. QALY
67  1997 Cost-effective analysis of mass screening for cervical cancer in Japan. CIS
68  1996 Costs and benefits of routine varicella vaccination in German children. BCR
69  1995 Cost effectiveness of hepatitis A prevention in France. IS